News
Impact of generic substitution in Finland
2011-04-26 Mandatory generic substitution was introduced in Finland on 1 April 2003. A recent study compared the impact of generic substitution on both originator and generic p...
Read more
Speculation that Hungary will slash drug reimbursement
2011-04-15 Hungary will next month announce economic reforms and there are fears that they could include cuts of about 30% to the national drug reimbursement bill. The size of...
Read more
Pharmacy chains in Norway do not stock generics
2011-04-15 It turns out that pharmacy chains in Norway do not stock the cheapest generic products. This finding came after the Norwegian Medicines Agency (NoMA) investigated af...
Read more
Birth pangs of the Medicines Patent Pool
2011-04-04 The Medicines Patent Pool (MPP) is an initiative designed to streamline patent licensing for generic versions of patented HIV treatments, in order to obtain lower pr...
Read more
EU patent with 23 countries
2011-04-04 The patent deadlock may yet be over, as 23 members of the EU have decided to leave behind the four others and work together to create a single patent system to prote...
Read more
Sandoz announces biosimilar rituximab
2011-02-03 Sandoz, the generic drug division of Swiss drug giant Novartis AG, announced on 10 January 2011 a phase II clinical trial for a biosimilar version of leading monoclo...
Read more
EMA recommends suspension of Octagam in all EU Member States-CHMP recommendation based on risk of thromboembolic reactions
2011-01-07 EMA has recommended the suspension of the marketing authorisations for Octagam (human normal immunoglobulin), from Octapharma GmbH and a recall of Octagam currently...
Read more
EU patents limp forward
2010-12-14 The Belgian EU Presidency is trying to break the deadlock over proposals for a single EU-wide patent system, which has been blocked for over a decade due to language...
Read more
Endo acquires US generics’ giant Qualitest
2010-12-09 Endo Pharmaceuticals is buying US generics’ giant Qualitest Pharmaceuticals for about Euros 850,000 in cash to expand its portfolio of pain drugs. This is its second...
Read more
Ranbaxy beats Teva to Alzheimer’s drug
2010-12-07 Aricept (donepezil hydrochloride), Eisai Pharmaceutical’s biggest selling drug, comes off patent in the US in November 2010. Thereafter donepezil hydrochloride may b...
Read more
COPD treatments
2010-12-02 An estimated 210 million people worldwide suffer from congestive obstructive pulmonary disease, COPD, and it is projected to be the third leading cause of death worl...
Read more
Rosiglitazone finally suspended
2010-12-01 When rosiglitazone was first authorised in the EU in 2000, it was contraindicated in patients with a history of cardiac failure. Since then, the Committee for Medici...
Read more
Last update: 2008-09-06 | 
Go Back | 
Print View